1.65
price up icon0.61%   0.01
after-market 시간 외 거래: 1.60 -0.05 -3.03%
loading

Immutep Limited Adr 주식(IMMP)의 최신 뉴스

pulisher
Jun 15, 2025

Millennium Management LLC Sells 19,242 Shares of Immutep Limited (NASDAQ:IMMP) - Defense World

Jun 15, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Has $98,000 Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Jun 08, 2025
pulisher
Jun 01, 2025

Immutep Ltd Highlights Immune System Innovations at Healthcare Conference - TipRanks

Jun 01, 2025
pulisher
May 08, 2025

Market Highlights: Immutep Limited ADR (IMMP) Ends on a Low Note at 1.93 - DWinneX

May 08, 2025
pulisher
May 06, 2025

Immutep stock soars on promising trial results - Investing.com Australia

May 06, 2025
pulisher
May 05, 2025

Immutep stock soars on promising trial results By Investing.com - Investing.com Nigeria

May 05, 2025
pulisher
Apr 29, 2025

Immutep Quarterly Activities Report Q3 FY25 - The Manila Times

Apr 29, 2025
pulisher
Apr 02, 2025

Immutep to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.

Apr 02, 2025
pulisher
Mar 24, 2025

Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au

Mar 24, 2025
pulisher
Feb 11, 2025

Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now? - AInvest

Feb 11, 2025
pulisher
Jan 14, 2025

Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025
pulisher
Dec 18, 2024

Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - GlobeNewswire

Dec 17, 2024
pulisher
Oct 29, 2024

Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance

Oct 29, 2024
pulisher
Oct 17, 2024

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - Yahoo Finance

Oct 17, 2024
pulisher
Jun 27, 2024

Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com

Jun 27, 2024
pulisher
Apr 18, 2024

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire

Apr 18, 2024
pulisher
Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024
pulisher
Nov 27, 2023

Immutep LimitedADR (IMMP) Price Target Increased by 5.10% to 2.59 - Nasdaq

Nov 27, 2023
pulisher
Mar 30, 2023

Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer - GlobeNewswire

Mar 30, 2023
pulisher
Nov 03, 2022

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead

Nov 03, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Apr 08, 2021

FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - Targeted Oncology

Apr 08, 2021
pulisher
Dec 30, 2020

Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch - Penny Stocks

Dec 30, 2020
pulisher
Sep 06, 2020

IMMPImmutep Latest Stock News & Market Updates - Stock Titan

Sep 06, 2020
pulisher
Apr 18, 2019

Immutep Ltd (IMMP) Stock Price, Trades & News - GuruFocus

Apr 18, 2019
pulisher
Dec 10, 2017

A Full List of Australia ADRs - Investing.com Australia

Dec 10, 2017
pulisher
Dec 05, 2017

Prima BioMed (IMMP) Stock Price, News & Analysis - MarketBeat

Dec 05, 2017
pulisher
May 14, 2017

Prima BioMed Share Price | NASDAQ IMMP Stock - Investing.com Australia

May 14, 2017
pulisher
May 13, 2017

Prima BioMed Stock Price Today | NASDAQ: IMMP Live - Investing.com

May 13, 2017
pulisher
May 13, 2017

Prima BioMed Stock Price Today | NASDAQ IMMP - Investing.com Canada

May 13, 2017
pulisher
Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - advfn.com

Jul 27, 2011
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):